BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3401 related articles for article (PubMed ID: 680624)

  • 21. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leucocyte migration under agarose: migration inhibition by soluble and tumor antigens with special reference to antimelanoma activity in healthy blacks.
    Tautz C; Khuen F; Ax W
    Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):155-61. PubMed ID: 4283006
    [No Abstract]   [Full Text] [Related]  

  • 23. The expression of tumor-associated antigens in primary and metastatic human malignant melanoma.
    Brüggen J; Bröcker EB; Suter L; Redmann K; Sorg C
    Behring Inst Mitt; 1984 May; (74):19-23. PubMed ID: 6477352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotype of human melanoma cells in different metastases.
    Bystryn JC; Bernstein P; Liu P; Valentine F
    Cancer Res; 1985 Nov; 45(11 Pt 2):5603-7. PubMed ID: 2413993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human melanoma tumor-specific antigens (II): Comparison of antigens from tumor cell plasma membranes of five melanoma patients.
    Khosravi M; Preddie E; Hartmann D; Lewis MG
    Cancer Biochem Biophys; 1980; 4(3):195-202. PubMed ID: 7438029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of a soluble tumor-associated antigen from human melanoma.
    Roth JA; Holmes EC; Reisfeld RA; Slocum HK; Morton DL
    Cancer; 1976 Jan; 37(1):104-10. PubMed ID: 1247946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human monoclonal antibodies directed against melanoma tumor-associated antigens.
    Kan-Mitchell J; Imam A; Kempf RA; Taylor CR; Mitchell MS
    Cancer Res; 1986 May; 46(5):2490-6. PubMed ID: 3697990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of tumor-specific antigen solubilized by hypertonic potassium chloride.
    Leonard EJ; Meltzer MS; Borsos T; Rapp HJ
    Natl Cancer Inst Monogr; 1972 Dec; 35():129-34. PubMed ID: 4572822
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
    Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid assay for stimulation of human lymphocytes by tumor-associated antigens.
    Roth JA; Grimm EA; Morton DL
    Cancer Res; 1976 Sep; 36(9 pt.1):3001-10. PubMed ID: 975069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of melanoma development and regression of melanoma in xiphophorine fish after treatment with immune RNA.
    Wurm F; Pauli G; Vielkind J
    Cancer Res; 1981 Sep; 41(9 Pt 1):3377-83. PubMed ID: 6167347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of a soluble tumor-associated antigen from human renal cell carcinoma by gradient acrylamide gel electrophoresis.
    Wright GL; Schellhammer PF; Faulconer RL
    Cancer Res; 1977 Nov; 37(11):4228-32. PubMed ID: 911404
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of IgG antibodies directed to a M(r) 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates.
    Berthier-Vergnes O; Portoukalian J; Lefthériotis E; Doré JF
    Cancer Res; 1994 May; 54(9):2433-9. PubMed ID: 8162593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.
    Gupta RK; Morton DL
    J Natl Cancer Inst; 1983 Jun; 70(6):993-1004. PubMed ID: 6190035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 171.